Finally, a previous study that showed increased sIL-1R2 levels in the cerebrospinal fluid of AD patients proposed that it might reflect a compensatory anti-inflammatory mechanism attempting to inhibit IL-1 receptor-mediated activity in the brain (Garlind et al., 1999). The gene discussed is IL1R2; the disease is Alzheimer disease.